A DNA Vaccine Encoding Lumazine Synthase from Brucella abortus Induces Protective Immunity in BALB/c Mice

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Infection and Immunity

• Publication date

  2002-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/IAI.70.5.2507-2511.2002PMID 11953389PMCID PMC127889
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Divergence in macromolecular assembly: X-ray crystallographic structure analysis of lumazine synthase from Brucella abortus.

  2000cited by this paper
• Single-shot plasmid DNA intrasplenic immunization for the production of monoclonal antibodies. Persistent expression of DNA.

  2000cited by this paper
• Effects of Opsonization and Gamma Interferon on Growth of Brucella melitensis 16M in Mouse Peritoneal Macrophages In Vitro

  2000cited by this paper
• A DNA immunization model study with constructs expressing the tick-borne encephalitis virus envelope protein E in different physical forms.

  1999cited by this paper
• DNA vaccination favours memory rather than effector B cell responses

  1999cited by this paper
• The 18-kDa cytoplasmic protein of Brucella species --an antigen useful for diagnosis--is a lumazine synthase.

  1999influential reference
• Gene vaccination: plasmid DNA is more than just a blueprint.

  1998cited by this paper
• A protein particle vaccine containing multiple malaria epitopes

  1997cited by this paper
• Nucleic acid vaccination of Brucella abortus ribosomal L7/L12 gene elicits immune response.

  1997influential reference
• Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex.

  1997cited by this paper
• Diagnosis of canine brucellosis by detection of serum antibodies against an 18 kDa cytoplasmic protein of Brucella spp.

  1997cited by this paper
• Identification of the major T-cell antigens present in the Brucella melitensis B115 protein preparation, Brucellergene OCB.

  1997cited by this paper
• Comparison of nucleic acid and protein immunization for induction of antibodies specific for HIV‐1 gp120

  1997cited by this paper
• Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization.

  1997cited by this paper
• Vaccination against tuberculosis by DNA injection

  1996cited by this paper
• Humoral immune response against lipopolysaccharide and cytoplasmic proteins of Brucella abortus in cattle vaccinated with B. abortus S19 or experimentally infected with Yersinia enterocolitica serotype 0:9

  1996cited by this paper
• Immunogenicity and protective efficacy of a tuberculosis DNA vaccine

  1996cited by this paper
• Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection.

  1996cited by this paper
• Serologic Responses of Brucella Abortus Strain 19 Calfhood-Vaccinated Cattle Following Adult Vaccination with Strain RB51

  1996cited by this paper
• Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA.

  1995cited by this paper
• Outer-membrane protein- and rough lipopolysaccharide-specific monoclonal antibodies protect mice against Brucella ovis.

  1995cited by this paper
• Cloning and sequence analysis of a newly identified Brucella abortus gene and serological evaluation of the 17-kilodalton antigen that it encodes

  1995cited by this paper
• Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes.

  1995cited by this paper
• Vaccination with Brucella abortus rough mutant RB51 protects BALB/c mice against virulent strains of Brucella abortus, Brucella melitensis, and Brucella ovis

  1994cited by this paper
• Lymphocyte proliferation in response to Brucella abortus 2308 or RB51 antigens in mice infected with strain 2308, RB51, or 19

  1994cited by this paper
• Modulation of immune responses in Balb/c mice vaccinated with Brucella abortus Cu-Zn superoxide dismutase synthetic peptide vaccine.

  1994cited by this paper
• Heterologous protection against influenza by injection of DNA encoding a viral protein.

  1993cited by this paper
• Cytokine production in the murine response to brucella infection or immunization with antigenic extracts.

  1993cited by this paper
• Endogenous gamma interferon mediates resistance to Brucella abortus infection

  1993cited by this paper
• Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni.

  1993cited by this paper
• Characterization of an 18-kilodalton Brucella cytoplasmic protein which appears to be a serological marker of active infection of both human and bovine brucellosis

  1993cited by this paper
• Protection conferred on mice by combinations of monoclonal antibodies directed against outer-membrane proteins or smooth lipopolysaccharide of Brucella.

  1992cited by this paper
• Comparative protection of mice against virulent and attenuated strains of Brucella abortus by passive transfer of immune T cells or serum

  1990cited by this paper
• An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs.

  1987cited by this paper
• Human brucellosis.

  1983cited by this paper
• Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

  1979cited by this paper
• Studies on the immune protection to murine experimental brucellosis conferred by Brucella fractions. I. Positive role of immune serum.

  1978cited by this paper
• Human brucellosis.

  1959cited by this paper

• Development of a plant-based vaccine against brucellosis: stable expression of Brucella abortus OMP25 in transgenic tobacco

  2025cites this paper
• Immunoinformatic design of a multivalent vaccine against Brucella abortus and its evaluation in a murine model using a DNA prime-protein boost strategy

  2024cites this paper
• Protective Immunity of a Novel Multi-Epitope Vaccine Encoding OMP31, TF, BLS, SOD, BP26, and L9 Against Brucella spp. Infection

  2024cites this paper
• Design of a novel multi-epitopes based vaccine against brucellosis

  2023cites this paper
• Immune response and recent advances in diagnosis and control of brucellosis

  2022cites this paper
• Evaluation of Brucellosis Vaccines: A Comprehensive Review

  2022influential citation
• Selection of Brucella abortus mimetic epitopes for fast diagnostic purposes in cattle

  2022cites this paper
• Protective efficacy of attenuated Salmonella Typhimurium strain expressing BLS, Omp19, PrpA, or SOD of Brucella abortus in goats

  2021cites this paper
• Proteomics of Brucella

  2020cites this paper
• Immune response to vaccine candidates based on different types of nanoscaffolded RBD domain of the SARS-CoV-2 spike protein

  2020cites this paper
• The advances in brucellosis vaccines.

  2019cites this paper
• Engineering self-assembling proteins to produce a safe and effective vaccine for Porcine Reproductive and Respiratory Syndrome

  2019cites this paper
• Preclinical Studies of NEAST (Neutralizing Equine Anti-Shiga To xin): A Potential Treatment for Prevention of Stec-Hus

  2019cites this paper
• jmbReview Substantial Protective Immunity Conferred by a Combination of Brucella abortus Recombinant Proteins against Brucella abortus 544 Infection in BALB / c Mice

  2019cites this paper
• Research progress in Brucella lumazine synthase ( BLS )

  2019cites this paper
• Evaluation of in ovo vaccination of DNA vaccines for Campylobacter control in broiler chickens.

  2019cites this paper
• Characterization of folding-sensitive nanobodies as tools to study the expression and quality of protein particle immunogens.

  2019cites this paper
• Intranasally administered anti-Brucella subunit vaccine formulation induces protective immune responses against nasal Brucella challenge.

  2019cites this paper
• Evaluation of immune responses induced by polymeric OMP25-BLS Brucella antigen.

  2018cites this paper
• Development of new generation of vaccines for Brucella abortus

  2018cites this paper
• Evaluation of a DNA vaccine encoding Brucella BvrR in BALB/c mice.

  2018cites this paper
• Effect of immunization routes and protective efficacy of Brucella antigens delivered via Salmonella vector vaccine

  2018cites this paper
• Biomedical Applications of Lumazine Synthase.

  2018cites this paper
• Brucellosis vaccines based on the open reading frames from genomic island 3 of Brucella abortus.

  2018cites this paper
• Immunogenicity evaluation of plasmids encoding Brucella melitensis Omp25 and Omp31 antigens in BALB/c mice

  2018cites this paper
• Active immunization with Brucella abortus S19 phage lysate elicits serum IgG that protects guinea pigs against virulent B. abortus and protects mice by passive immunization.

  2017cites this paper
• Effect of Phosphate Ion on the Structure of Lumazine Synthase, an Antigen Presentation System From Bacillus anthracis.

  2017cites this paper
• Enhancing the Biological Relevance of Machine Learning Classifiers for Reverse Vaccinology

  2017cites this paper
• Brucella lipopolysaccharide reinforced Salmonella delivering Brucella immunogens protects mice against virulent challenge.

  2017cites this paper
• Development and trial of vaccines against Brucella

  2017cites this paper
• Vaccines and Vaccine Candidates against Brucellosis

  2016cites this paper
• The Case for Live Attenuated Vaccines against the Neglected Zoonotic Diseases Brucellosis and Bovine Tuberculosis

  2016cites this paper
• Meta-Analysis and Advancement of Brucellosis Vaccinology

  2016cites this paper
• Development and Evaluation of Novel Vaccination Strategies for Campylobacter Control in Poultry

  2015cites this paper
• Brucella abortus S19 and RB51 vaccine immunogenicity test: Evaluation of three mice (BALB/c, Swiss and CD-1) and two challenge strains (544 and 2308).

  2015cites this paper
• Recent advances in Brucella abortus vaccines

  2015cites this paper
• Expression of the Multimeric and Highly Immunogenic Brucella spp. Lumazine Synthase Fused to Bovine Rotavirus VP8d as a Scaffold for Antigen Production in Tobacco Chloroplasts

  2015cites this paper
• Evaluation of immunogenicity and protective efficacy of a plasmid DNA vaccine encoding ribosomal protein L9 of Brucella abortus in BALB/c mice.

  2014cites this paper
• Immunization with Brucella VirB Proteins Reduces Organ Colonization in Mice through a Th1-Type Immune Response and Elicits a Similar Immune Response in Dogs

  2014cites this paper
• A DNA vaccine encoding p39 and sp41 of Brucella melitensis induces protective immunity in BALB/c mice

  2014cites this paper
• Epidemiology of Bovine Brucellosis-a review of lite rature

  2014cites this paper
• Evaluation of the immunogenicity and the protective efficacy in mice of a DNA vaccine encoding SP41 from Brucella melitensis.

  2013cites this paper
• A History of the Development of Brucella Vaccines

  2013cites this paper
• Construction of an expression plasmid (vector) encoding Brucella melitensis outer membrane protein, a candidate for DNA vaccine.

  2013cites this paper
• Tandem repeats of the extracellular domain of Matrix 2 influenza protein exposed in Brucella lumazine synthase decameric carrier molecule induce protection in mice.

  2013cites this paper
• Progress in Brucella vaccine development

  2013cites this paper
• Protective effect of a DNA vaccine containing an open reading frame with homology to an ABC-type transporter present in the genomic island 3 of Brucella abortus in BALB/c mice.

  2013cites this paper
• The vaccine candidate BLSOmp31 protects mice against Brucella canis infection.

  2013cites this paper
• A Polymeric Protein Induces Specific Cytotoxicity in a TLR4 Dependent Manner in the Absence of Adjuvants

  2012cites this paper
• Brucellosis Vaccines: An Overview

  2012cites this paper
• Immunization of Mice with Recombinant Protein CobB or AsnC Confers Protection against Brucella abortus Infection

  2012cites this paper
• Evaluation of protective effect of DNA vaccines encoding the BAB1_0263 and BAB1_0278 open reading frames of Brucella abortus in BALB/c mice.

  2012cites this paper
• Induction of T helper 1 response by immunization of BALB/c mice with the gene encoding the second subunit of Echinococcus granulosus antigen B (EgAgB8/2)

  2012cites this paper
• Acellular vaccines for ovine brucellosis: a safer alternative against a worldwide disease

  2012cites this paper
• Immunization of mice with recombinant S-adenosyl-L-homocysteine hydrolase protein confers protection against Brucella melitensis infection.

  2011cites this paper
• DNA VACCINATION OF BISON TO BRUCELLAR ANTIGENS ELICITS ELEVATED ANTIBODY AND IFN-γ RESPONSES

  2011cites this paper
• Co-immunization with interlukin-18 enhances the protective efficacy of liposomes encapsulated recombinant Cu-Zn superoxide dismutase protein against Brucella abortus.

  2011cites this paper
• Estudio de Lumazina Sintasa de Brucella como proteína transportadora de antígenos: relación entre estructura, estabilidad e inmunogenicidad

  2011cites this paper
• Confronting the barriers to develop novel vaccines against brucellosis

  2011cites this paper
• Immunoproteomic analysis of Brucella melitensis and identification of a new immunogenic candidate protein for the development of brucellosis subunit vaccine.

  2011cites this paper
• Redox mechanism of lumazine at a glassy carbon electrode

  2010cites this paper
• An IL-15 adjuvant enhances the efficacy of a combined DNA vaccine against Brucella by increasing the CD8+ cytotoxic T cell response.

  2010cites this paper
• Recent Advances in Understanding Immunity Against Brucellosis: Application for Vaccine Development

  2010cites this paper
• Towards a Brucella vaccine for humans.

  2010cites this paper
• Liposomal delivery of p-ialB and p-omp25 DNA vaccines improves immunogenicity but fails to provide full protection against B. melitensis challenge

  2010cites this paper
• Vaccination with recombinant Semliki Forest virus particles expressing translation initiation factor 3 of Brucella abortus induces protective immunity in BALB/c mice.

  2009cites this paper
• Protection of mice from Brucella infection by immunization with attenuated Salmonella enterica serovar typhimurium expressing A L7/L12 and BLS fusion antigen of Brucella.

  2009cites this paper
• Brucella spp. lumazine synthase as a bovine rotavirus antigen delivery system.

  2009cites this paper
• The polymeric antigen BLSOmp31 confers protection against Brucella ovis infection in rams.

  2009cites this paper
• Evaluation of Brucella abortus DNA and RNA vaccines expressing Cu-Zn superoxide dismutase (SOD) gene in cattle.

  2008cites this paper
• RESPUESTA INMUNE EN HAMSTERES INDUCIDA POR LOS POLIPEPTIDOS EHCP112 Y EHADH112 DE ENTAMOEBA HISTOLITICA CODIFICADOS POR UNA VACUNA DE DNA

  2008cites this paper
• A DNA vaccine coding for the chimera BLSOmp31 induced a better degree of protection against B. ovis and a similar degree of protection against B. melitensis than Rev.1 vaccination.

  2007cites this paper
• Nasal immunization with recombinant Brucella melitensis bp26 and trigger factor with cholera toxin reduces B. melitensis colonization.

  2007cites this paper
• A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination.

  2007cites this paper
• The identification of two protective DNA vaccines from a panel of five plasmid constructs encoding Brucella melitensis 16M genes.

  2007cites this paper
• A Combined DNA Vaccine Encoding BCSP31, SOD, and L7/L12 Confers High Protection Against Brucella abortus 2308 by Inducing Specific CTL Responses

  2007influential citation
• A combined DNA vaccine enhances protective immunity against Mycobacterium tuberculosis and Brucella abortus in the presence of an IL-12 expression vector.

  2007cites this paper
• Concerning Brucella LPS: genetic analysis and role in host- agent interaction

  2006cites this paper
• A Polymeric Bacterial Protein Activates Dendritic Cells via TLR41

  2006cites this paper
• Brucella abortus: inmunidad, vacunas y estrategias de prevención basadas en ácidos nucleicos

  2006cites this paper
• Future trends in human brucellosis treatment

  2006cites this paper
• This information is current as Dendritic Cells via TLR 4 A Polymeric Bacterial Protein Activates

  2006cites this paper
• Brucella and Bioterrorism

  2006cites this paper
• Evaluation of unmarked deletion mutants as improved Brucella vaccine strains in the mouse and goat models

  2006cites this paper
• Protective Immunity Elicited by a Divalent DNA Vaccine Encoding Both the L7/L12 and Omp16 Genes of Brucella abortus in BALB/c Mice

  2006cites this paper
• Evaluation of novel Brucella melitensis unmarked deletion mutants for safety and efficacy in the goat model of brucellosis.

  2006cites this paper
• Evaluation of Brucella abortus DNA vaccine by expression of Cu-Zn superoxide dismutase antigen fused to IL-2.

  2006cites this paper
• Brucella abortus : antecedentes y avances en aspectos de patogenesis, diagnóstico y control

  2006cites this paper
• Selection of Protective Epitopes for Brucella melitensis by DNA Vaccination

  2005cites this paper
• Vaccination with the Recombinant Brucella Outer Membrane Protein 31 or a Derived 27-Amino-Acid Synthetic Peptide Elicits a CD4+ T Helper 1 Response That Protects against Brucella melitensis Infection

  2005cites this paper
• Brucellosis – new aspects of an old disease

  2005cites this paper
• A DNA Vaccine Coding for the Brucella Outer Membrane Protein 31 Confers Protection against B. melitensis and B. ovis Infection by Eliciting a Specific Cytotoxic Response

  2005cites this paper
• An investigation of novel DNA based vaccines for protection against Brucellosis

  2005cites this paper
• Brucelosis: una revisión práctica

  2005cites this paper
• Multiple display of a protein domain on a bacterial polymeric scaffold

  2005cites this paper
• Brucella spp. lumazine synthase: a novel antigen delivery system.

  2005cites this paper
• Brucella abortus RB51 vaccine: Testing its Spectrum of Protective and Curative Characteristics

  2004cites this paper
• High Order Quaternary Arrangement Confers Increased Structural Stability to Brucella sp. Lumazine Synthase*

  2004cites this paper
• Engineering of a polymeric bacterial protein as a scaffold for the multiple display of peptides

  2004cites this paper
• A DNA Vaccine Encoding Cu,Zn Superoxide Dismutase of Brucella abortus Induces Protective Immunity in BALB/c Mice

  2003influential citation